Europe — EMA
Omvoh (Mirikizumab)
Mirikizumab, the active ingredient in Omvo, is a monoclonal antibody presented as a solution for intravenous infusion use. It targets inflammatory pathways and is indicated for certain chronic inflammatory conditions in…
Request sourcing
1
Pack/s
What is Mirikizumab?
Mirikizumab, the active ingredient in Omvo, is a monoclonal antibody presented as a solution for intravenous infusion use. It targets inflammatory pathways and is indicated for certain chronic inflammatory conditions in adult patients.
GNH USA supplies Omvo as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and clinics worldwide.
What is Mirikizumab used for?
Omvo is a targeted therapy that focuses .... - Ulcerative colitis: ... ... ... ... .... ... ... ....
Product details
Drug
Mirikizumab
Route
Intravenous Use
Manufacturer
Eli Lilly Nederland B.V.
Origin
EU
